Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Clinical & Developmental Immunology|May 28, 2013
Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brainWim Maes, Tina Verschuere, Anaïs Van Hoylandt, et al.Journal for Immunotherapy of Cancer|December 18, 2015
The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancerThaïs Baert, Tina Verschuere, Anaïs Van Hoylandt, et al.Expert Review of Neurotherapeutics|April 8, 2011
Galectin-1 and immunotherapy for brain cancerTina Verschuere, Steven De Vleeschouwer, Florence Lefranc, et al.Brain Pathology (Zurich, Switzerland)|September 12, 2009
Dendritic cell therapy of high-grade gliomasStefaan Van Gool, Wim Maes, Hilko Ardon, et al.Oncoimmunology|May 4, 2016
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease courseAn Coosemans, Judit Decoene, Thaïs Baert, et al.Science Translational Medicine|March 4, 2016
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade gliomaAbhishek D Garg, Lien Vandenberk, Carolien Koks, et al.International Journal of Cancer|July 7, 2017
Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockadeJoost Dejaegher, Tina Verschuere, Ellen Vercalsteren, et al.Anticancer Research|September 12, 2013
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcomaAn Coosemans, Anke Vanderstraeten, Sandra Tuyaerts, et al.Anticancer Research|December 11, 2013
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trialAn Coosemans, Anke Vanderstraeten, Sandra Tuyaerts, et al.Oncoimmunology|April 9, 2016
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade gliomaLien Vandenberk, Abhishek D Garg, Tina Verschuere, et al.Pageof 2